Home
/
MACROGENICS INC
/
Financials
/
Quarterly
MACROGENICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MACROGENICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$72.84M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$22.24M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$13.19M
May 13, 2025
Q3
2025
Sep 30, 2024
$110.71M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$10.80M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$9.10M
May 13, 2025
Q3
2024
Sep 30, 2023
$10.40M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$13.14M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$24.50M
May 9, 2024
Q3
2023
Sep 30, 2022
$41.73M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$26.01M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$11.10M
May 9, 2023
Q3
2022
Sep 30, 2021
$15.66M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$30.76M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$16.88M
May 3, 2022
Q3
2021
Sep 30, 2020
$18.25M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$20.26M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$13.68M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$18.74M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$10.59M
Jul 31, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.82M
Nov 12, 2025
Q3
2025
Jun 30, 2025
($36.25M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($36.25M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($41.04M)
May 13, 2025
Q2
2025
Mar 31, 2025
($41.04M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($41.04M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
$56.31M
Nov 12, 2025
Q2
2025
Jun 30, 2024
($55.66M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($55.66M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($52.19M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($52.19M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($52.19M)
May 13, 2025
Q3
2024
Sep 30, 2023
$17.55M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$57.47M
Aug 6, 2024
Q3
2024
Jun 30, 2023
$57.47M
Nov 5, 2024
Q3
2024
Mar 31, 2023
($38.01M)
Nov 5, 2024
Q1
2024
Mar 31, 2023
($38.01M)
May 9, 2024
Q2
2024
Mar 31, 2023
($38.01M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
($24.81M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($41.30M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$18.64M
Nov 12, 2025
Q2
2025
Jun 30, 2025
($36.76M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($42.62M)
May 13, 2025
Q3
2025
Sep 30, 2024
$54.19M
Nov 12, 2025
Q2
2025
Jun 30, 2024
($58.18M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($53.75M)
May 13, 2025
Q3
2024
Sep 30, 2023
($35.50M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($44.96M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($38.43M)
May 9, 2024
Q3
2023
Sep 30, 2022
($24.96M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($41.81M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($66.64M)
May 9, 2023
Q3
2022
Sep 30, 2021
($52.99M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($40.28M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($51.29M)
May 3, 2022
Q3
2021
Sep 30, 2020
($36.14M)
Nov 2, 2021
Q2
2021
Jun 30, 2020
($47.31M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
($45.45M)
Apr 29, 2021
Q3
2020
Sep 30, 2019
($37.94M)
Nov 4, 2020
Q2
2020
Jun 30, 2019
($52.97M)
Jul 31, 2020